Delaware Technology Park
5 Innovation Way, Suite 100
Newark, DE 19711

Tel: 302-224-3450x305
Fax: 302-224-3457

AthenaBio provides libraries of new bioactive molecules for screening by the pharmaceutical and agricultural chemical industries. These molecules are isolated from both plants and microbes through patented processes that focus on stimulating bioactive defense molecule production by living organisms. These processes yield new libraries in which each element can be reproducibly manufactured and scaled up. AthenaBio uses proprietary technology to culture new species of microbes, each of which is stimulated to yield new bioactive molecules. This revolutionary technology is also the key to AthenaBio''s upside potential: the cultivation of new microbes causing known diseases. We have a systematic approach to discovering the next new pathogen like Helicobacter pylori, the recently discovered causitive agent behind gastric ulcers.